Despite higher total investment spend, the number of insurtech deals fell by 30% in June from a year ago, mostly due to a significant slowdown in U.S.-based insurtech deals, according to the Insurtech Monthly Update from U.S.-based analyst Keefe, Bruyette & Woods Inc.